Company Case Study by  Kaneka Medical Europe | Mitochondrial health as the new frontier of evidence-based wellbeing and longevity

Company Case Study by Kaneka Medical Europe | Mitochondrial health as the new frontier of evidence-based wellbeing and longevity

Tuesday, May 5, 2026 10:55 AM to 11:25 AM · 30 min. (Europe/Paris)
Vitafoods Insights Theatre, 6H2
Cognitive and Emotional HealthLifelong HealthMarket Trends and Consumer Insights

Information

As the longevity category matures, mitochondrial and sub-cellular health is coming into sharp focus. In this presentation, Nick Morgan, founder of Nutrition Integrated, will explore how mitochondrial health is emerging as a defining pillar of future nutraceutical innovation.

Grounded in market insight and real-world examples, the session will highlight how brands are translating complex science into relevant, commercially viable products with evidence-based ingredients that meet genuine consumer needs, from cardiovascular health and cognition to women’s health, energy, and metabolic health.

By viewing this session, the sponsor may contact you with product and service information. You can unsubscribe or contact the sender anytime. See the Privacy Policy (https://privacy.informa.com/policies/en/) for details.

This session will be recorded on site and will be made available for on-demand viewing from 11th May till 8th June 2026.
Availability
Recorded on siteIn-person
Event Type
Company Case Study
Accessibility
Free-to-attend
Kaneka Medical Europe N.V.3B102Kaneka is the global leader in the manufacturing of Kaneka Ubiquinol™ - the clinical proven bioactive and bioidentical form of CoQ10. Kaneka Ubiquinol™ supports mitochondrial energy production, antioxidant protection, and biogenesis, making it an essential ingredient in numerous health applications. Its proven efficacy spans 100+ scientific studies, 80+ patents, and 45+ years of research in health of mitochondria, cardiovascular system, cognition, menopause, reproduction, energy production, vitality and optimal wellbeing. It has been listed in 50+ countries and 1000+ practitioner and OTC nutraceutical brands since 2006. Kaneka Ubiquinol’s strict adherence to the highest manufacturing standards guarantees a stable ingredient, free from impurities, meeting rigorous standards and sustainability requirements, and setting the global benchmark for production quality via its unique, globally-patented yeast fermentation process. Kaneka Ubiquinol™ carries multiple certifications, including HALAL, GRAS, HACCP, NDI, KOSHER, GMP, ISO 140001 and ISO 22000, Non-GMO, Non-Animal Origin, and OSHMS. Trusted by professionals worldwide, Kaneka Ubiquinol’s distinctive Seal of Quality is the hallmark of Kaneka Ubiquinol™ science, manufacturing and ingredient efficacy, found on all trusted Ubiquinol food supplements. Kaneka Ubiquinol® is the proud winner of multiple awards, including: · Tmall Global Marketing Innovation Award 2025 · Finalist of NutraIngredients-Asia Innovation in Women's Health Award 2025 · Natural Health Products New Zealand Forbes Packaging Marketing Award 2025 · CMA Raw Material Supplier of the Year Award 2024 · NutraIngredients-Asia Healthy Ageing Ingredient of the Year Award 2024

Join the event!

See all the content and easy-to-use features by logging in or registering!